Trait centric view

1. Trait name:	Subcutaneous fat thickness
   Ontology terms:	VT:1000135

   199 genes are associated with this trait, with QTL/association found

   • AASS: Aminoadipate-semialdehyde synthase
     evidenced by: QTL:23380;
   • ABHD4: Abhydrolase domain containing 4, N-acyl phospholipase B
     evidenced by: QTL:257711;
   • ABL1: ABL proto-oncogene 1, non-receptor tyrosine kinase
     evidenced by: QTL:95673;
   • ACAA1: Acetyl-CoA acyltransferase 1
     evidenced by: QTL:297333; QTL:297335; QTL:297341; QTL:297345; QTL:297349;
   • ADAM32: ADAM metallopeptidase domain 32
     evidenced by: QTL:31222;
   • ADAMTS2: ADAM metallopeptidase with thrombospondin type 1 motif 2
     evidenced by: QTL:315099;
   • AFF2: ALF transcription elongation factor 2
     evidenced by: QTL:312363;
   • AGL: Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
     evidenced by: QTL:12068; QTL:23175; QTL:23176;
   • AGPAT5: 1-acylglycerol-3-phosphate O-acyltransferase 5
     evidenced by: QTL:261625;
   • ALPK2: Alpha kinase 2
     evidenced by: QTL:258451;
   • AMH: Anti-Mullerian hormone
     evidenced by: QTL:258452; QTL:258453;
   • ANKRD31: Ankyrin repeat domain 31
     evidenced by: QTL:28085;
   • ANKRD55: Ankyrin repeat domain 55
     evidenced by: QTL:315117;
   • ANKS1A: Ankyrin repeat and sterile alpha motif domain containing 1A
     evidenced by: QTL:258509; QTL:258510; QTL:258511;
   • ANO1: Anoctamin 1
     evidenced by: QTL:262684; QTL:262686; QTL:262690;
   • ANO9: Anoctamin 9
     evidenced by: QTL:262683; QTL:262689;
   • APBB2: Amyloid beta precursor protein binding family B member 2
     evidenced by: QTL:297654;
   • APOE: Apolipoprotein E
     evidenced by: QTL:126045;
   • APOM: Apolipoprotein M
     evidenced by: QTL:12128; QTL:12129; QTL:12130; QTL:12131;
   • ASCC3: Activating signal cointegrator 1 complex subunit 3
     evidenced by: QTL:23370;
   • ATP2B1: ATPase, Ca++ transporting, plasma membrane 1
     evidenced by: QTL:9878;
   • B3GLCT: Beta 3-glucosyltransferase
     evidenced by: QTL:315114;
   • BBS7: Bardet-Biedl syndrome 7
     evidenced by: QTL:139266;
   • BMP5: Bone morphogenetic protein 5
     evidenced by: QTL:16995;
   • BTG2: BTG family, member 2
     evidenced by: QTL:17579;
   • C7H6ORF106: Chromosome 6 open reading frame 106 ortholog
     evidenced by: QTL:312341;
   • CAAP1: Caspase activity and apoptosis inhibitor 1
     evidenced by: QTL:23337;
   • CABLES1: Cdk5 and Abl enzyme substrate 1
     evidenced by: QTL:23307;
   • CAMK1D: Calcium/calmodulin-dependent protein kinase ID
     evidenced by: QTL:31225;
   • CART: Cocaine- and amphetamine-regulated transcript
     evidenced by: QTL:8645; QTL:8646;
   • CAST: Calpastatin
     evidenced by: QTL:125087; QTL:17498;
   • CCBE1: Collagen and calcium binding EGF domains 1
     evidenced by: QTL:216341; QTL:258494; QTL:258495; QTL:315110;
   • CCDC39: Coiled-coil domain containing 39
     evidenced by: QTL:31227;
   • CCKAR: Cholecystokinin A receptor
     evidenced by: QTL:10600;
   • CCND2: Cyclin D2
     evidenced by: QTL:258004; QTL:258005; QTL:258006; QTL:258007; QTL:258008; QTL:258009; QTL:258010; QTL:258011; QTL:297649; QTL:315101; QTL:315112;
   • CCSER1: Coiled-coil serine rich protein 1
     evidenced by: QTL:216298;
   • CDH19: Cadherin 19
     evidenced by: QTL:258472;
   • CDH20: Cadherin 20
     evidenced by: QTL:258444; QTL:258486; QTL:258487; QTL:258488; QTL:258489;
   • CDHR2: Cadherin related family member 2
     evidenced by: QTL:315100;
   • CGNL1: Cingulin like 1
     evidenced by: QTL:315109;
   • CIART: Circadian associated repressor of transcription
     evidenced by: QTL:218047;
   • CMIP: C-Maf inducing protein
     evidenced by: QTL:23284;
   • COL21A1: Collagen, type XXI, alpha 1
     evidenced by: QTL:259879; QTL:259880; QTL:259883; QTL:259885; QTL:259889; QTL:259890;
   • COL4A3BP: Collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
     evidenced by: QTL:28084;
   • COPA: Coatomer protein complex subunit alpha
     evidenced by: QTL:122134;
   • CPLX4: Complexin 4
     evidenced by: QTL:285903;
   • CRH: Corticotropin releasing hormone
     evidenced by: QTL:16958;
   • CTNNBL1: Catenin, beta like 1
     evidenced by: QTL:18536; QTL:18537;
   • CTSD: Cathepsin D
     evidenced by: QTL:11857; QTL:11904; QTL:11906; QTL:11909;
   • CTSK: Cathepsin K
     evidenced by: QTL:10410;
   • CTSS: Cathepsin S
     evidenced by: QTL:12119;
   • DENND2D: DENN/MADD domain containing 2D
     evidenced by: QTL:31228;
   • DGAT2: Diacylglycerol O-acyltransferase 2
     evidenced by: QTL:18538;
   • DIO3: Deiodinase, iodothyronine, type III
     evidenced by: QTL:17881; QTL:17882; QTL:17883;
   • DKC1: Dyskerin pseudouridine synthase 1
     evidenced by: QTL:147176; QTL:147180;
   • DOCK10: Dedicator of cytokinesis 10
     evidenced by: QTL:23315;
   • DOCK5: Dedicator of cytokinesis 5
     evidenced by: QTL:31226;
   • DOCK7: Dedicator of cytokinesis 7
     evidenced by: QTL:166708;
   • DST: Dystonin
     evidenced by: QTL:31232; QTL:312432;
   • EIF2C2: Eukaryotic translation initiation factor 2C, 2
     evidenced by: QTL:23335;
   • EPAS1: Endothelial PAS domain protein 1
     evidenced by: QTL:31220;
   • EYA2: EYA transcriptional coactivator and phosphatase 2
     evidenced by: QTL:262691;
   • F8: Coagulation factor VIII
     evidenced by: QTL:147175; QTL:147179; QTL:147183;
   • FABP3: Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)
     evidenced by: QTL:12859;
   • FABP4: Fatty acid binding protein 4, adipocyte
     evidenced by: QTL:7263; QTL:7264; QTL:7265; QTL:7270; QTL:7271; QTL:7272;
   • FABP5: Fatty acid binding protein 5 (psoriasis-associated)
     evidenced by: QTL:5078; QTL:5079; QTL:5080;
   • FADS2: Fatty acid desaturase 2
     evidenced by: QTL:31548;
   • FASN: Fatty acid synthase
     evidenced by: QTL:125086; QTL:193128;
   • FTO: Fat mass and obesity associated
     evidenced by: QTL:12121; QTL:12123; QTL:32772; QTL:32773; QTL:32774; QTL:32775; QTL:32785; QTL:32786;
   • GAB3: GRB2 associated binding protein 3
     evidenced by: QTL:147177; QTL:147181;
   • GALR3: Galanin receptor 3
     evidenced by: QTL:23282;
   • GBP1: Guanylate binding protein 1, interferon-inducible
     evidenced by: QTL:238179; QTL:238181;
   • GBP5: Guanylate binding protein 5
     evidenced by: QTL:238177;
   • GC: Group-specific component (vitamin D binding protein)
     evidenced by: QTL:126060;
   • GCNT4: Glucosaminyl (N-acetyl) transferase 4, core 2
     evidenced by: QTL:28086;
   • GDA: Guanine deaminase
     evidenced by: QTL:12660;
   • GH1: Growth hormone 1
     evidenced by: QTL:4200;
   • GHRHR: Growth hormone releasing hormone receptor
     evidenced by: QTL:1191;
   • GLIPR1: GLI pathogenesis related 1
     evidenced by: QTL:261719; QTL:261720; QTL:261721; QTL:261722; QTL:261723;
   • GMDS: GDP-mannose 4,6-dehydratase
     evidenced by: QTL:259498;
   • GNRHR: Gonadotropin-releasing hormone receptor
     evidenced by: QTL:126047;
   • GOLGA3: Golgin A3
     evidenced by: QTL:216293;
   • GPC3: Glypican 3
     evidenced by: QTL:257710;
   • GPHN: Gephyrin
     evidenced by: QTL:216295;
   • GPIHBP1: Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1
     evidenced by: QTL:65395; QTL:65396;
   • GPX2: Glutathione peroxidase 2
     evidenced by: QTL:282938; QTL:282940;
   • GRM4: Glutamate receptor, metabotropic 4
     evidenced by: QTL:258500;
   • GSK3A: Glycogen synthase kinase 3 alpha
     evidenced by: QTL:65398; QTL:65399; QTL:65400;
   • HECW1: HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
     evidenced by: QTL:283222;
   • HMGA1: High mobility group AT-hook 1
     evidenced by: QTL:12653; QTL:12654; QTL:12655; QTL:12656; QTL:12657;
   • HNF1A: HNF1 homeobox A
     evidenced by: QTL:23613; QTL:23616;
   • HSD17B4: Hydroxysteroid 17-beta dehydrogenase 4
     evidenced by: QTL:122477;
   • HSF5: Heat shock transcription factor family member 5
     evidenced by: QTL:31224;
   • IDH3B: Isocitrate dehydrogenase 3 (NAD+) beta
     evidenced by: QTL:19440;
   • IGF2: Insulin-like growth factor 2 (somatomedin A)
     evidenced by: QTL:11894; QTL:11899; QTL:7299; QTL:7301; QTL:7302; QTL:7303;
   • IGSF3: Immunoglobulin superfamily, member 3
     evidenced by: QTL:23314; QTL:23316;
   • IL12A: Interleukin 12a
     evidenced by: QTL:3087;
   • INPP5K: Inositol polyphosphate-5-phosphatase K
     evidenced by: QTL:23992;
   • INPPL1: Inositol polyphosphate phosphatase-like 1
     evidenced by: QTL:18530;
   • IP6K3: Inositol hexakisphosphate kinase 3
     evidenced by: QTL:297653;
   • KCNQ5: Potassium voltage-gated channel subfamily Q member 5
     evidenced by: QTL:262688;
   • KCNT2: Potassium channel, subfamily T, member 2
     evidenced by: QTL:23356;
   • KDM2A: Lysine (K)-specific demethylase 2A
     evidenced by: QTL:17582;
   • KDSR: 3-ketodihydrosphingosine reductase
     evidenced by: QTL:258436; QTL:258476;
   • KHDRBS2: KH domain containing, RNA binding, signal transduction associated 2
     evidenced by: QTL:312335;
   • KIF14: Kinesin family member 14
     evidenced by: QTL:95674;
   • LDHA: Lactate dehydrogenase A
     evidenced by: QTL:160586; QTL:28216; QTL:9816; QTL:9818; QTL:9820;
   • LEP: Leptin
     evidenced by: QTL:23087; QTL:23088;
   • LEPR: Leptin receptor
     evidenced by: QTL:106315; QTL:23094; QTL:23095; QTL:23096; QTL:296724; QTL:296725; QTL:296726; QTL:296733; QTL:296734; QTL:296735; QTL:4967; QTL:4968; QTL:4969; QTL:66009; QTL:66010; QTL:7559; QTL:7562; QTL:7565;
   • LOC100738152: Transcription factor SOX-6-like
     evidenced by: QTL:56221; QTL:56222; QTL:56223;
   • MAGEL2: MAGE-like 2
     evidenced by: QTL:17872;
   • MATN3: Matrilin 3
     evidenced by: QTL:126057;
   • MBIP: MAP3K12 binding inhibitory protein 1
     evidenced by: QTL:216296;
   • MC4R: Melanocortin 4 receptor
     evidenced by: QTL:10627; QTL:10628; QTL:10629; QTL:125085; QTL:126064; QTL:18521; QTL:21339; QTL:258447; QTL:258493; QTL:285902; QTL:9800; QTL:9801; QTL:9802; QTL:9803;
   • ME1: Malic enzyme 1, NADP(+)-dependent, cytosolic
     evidenced by: QTL:12646;
   • MEG3: Maternally expressed 3
     evidenced by: QTL:164017; QTL:164018; QTL:164019;
   • MIR206: MicroRNA mir-206
     evidenced by: QTL:66003;
   • MOCS1: Molybdenum cofactor synthesis 1
     evidenced by: QTL:23285;
   • MRC2: Mannose receptor C type 2
     evidenced by: QTL:259499;
   • MRPL36: Mitochondrial ribosomal protein L36
     evidenced by: QTL:23319;
   • MRPS6: Mitochondrial ribosomal protein S6
     evidenced by: QTL:259892;
   • MSI2: Musashi RNA binding protein 2
     evidenced by: QTL:259478;
   • MTHFR: Methylenetetrahydrofolate reductase
     evidenced by: QTL:126041; QTL:126043;
   • MUC4: Mucin 4, cell surface associated
     evidenced by: QTL:24022;
   • MX2: Myxovirus (influenza virus) resistance 2 (mouse)
     evidenced by: QTL:31223;
   • MYOD1: Myogenic differentiation 1
     evidenced by: QTL:28217;
   • MYOG: Myogenin (myogenic factor 4)
     evidenced by: QTL:8657;
   • NADSYN1: NAD synthetase 1
     evidenced by: QTL:315098;
   • NALCN: Sodium leak channel, non-selective
     evidenced by: QTL:312367;
   • NIPBL: NIPBL cohesin loading factor
     evidenced by: QTL:283223;
   • NKAIN2: Sodium/potassium transporting ATPase interacting 2
     evidenced by: QTL:258468; QTL:258469; QTL:258470;
   • NOL4: Nucleolar protein 4
     evidenced by: QTL:19383;
   • NR0B2: Nuclear receptor subfamily 0, group B, member 2
     evidenced by: QTL:10604;
   • NUDT3: Nudix (nucleoside diphosphate linked moiety X)-type motif 3
     evidenced by: QTL:258502; QTL:258503;
   • NUMA1: Nuclear mitotic apparatus protein 1
     evidenced by: QTL:23295;
   • OSBPL1A: Oxysterol binding protein-like 1A
     evidenced by: QTL:23342;
   • OXTR: Oxytocin receptor
     evidenced by: QTL:126053;
   • PACSIN1: Protein kinase C and casein kinase substrate in neurons 1
     evidenced by: QTL:258505;
   • PALMD: Palmdelphin
     evidenced by: QTL:122135;
   • PDE1C: Phosphodiesterase 1C, calmodulin-dependent 70kDa
     evidenced by: QTL:23271;
   • PHLPP1: PH domain and leucine rich repeat protein phosphatase 1
     evidenced by: QTL:258438; QTL:258439; QTL:258440; QTL:258479;
   • PIK3C3: Phosphatidylinositol 3-kinase, catalytic subunit type 3
     evidenced by: QTL:17632;
   • PLN: Phospholamban
     evidenced by: QTL:3093;
   • PPARA: Peroxisome proliferator-activated receptor alpha
     evidenced by: QTL:31316; QTL:31317;
   • PPARD: Peroxisome proliferator-activated receptor delta
     evidenced by: QTL:71077; QTL:71078; QTL:71079; QTL:71080; QTL:71084; QTL:71085;
   • PPARG: Peroxisome proliferator activated receptor gamma
     evidenced by: QTL:126067;
   • PPP4R4: Protein phosphatase 4 regulatory subunit 4
     evidenced by: QTL:315104;
   • PREX2: Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2
     evidenced by: QTL:312366;
   • PRICKLE2: Prickle planar cell polarity protein 2
     evidenced by: QTL:259479;
   • PRKCE: Protein kinase C epsilon
     evidenced by: QTL:259497;
   • PTGIS: Prostaglandin I2 (prostacyclin) synthase
     evidenced by: QTL:19442;
   • PTK2B: Protein tyrosine kinase 2 beta
     evidenced by: QTL:312362;
   • RELCH: RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing
     evidenced by: QTL:258441; QTL:258480;
   • RETSAT: Retinol saturase
     evidenced by: QTL:122131;
   • RNF152: Ring finger protein 152
     evidenced by: QTL:216338; QTL:258442; QTL:258443; QTL:258481;
   • RPH3AL: Rabphilin 3A like (without C2 domains)
     evidenced by: QTL:312368; QTL:312369;
   • RYR1: Ryanodine receptor 1 (skeletal)
     evidenced by: QTL:258454; QTL:7671;
   • SCD: Stearoyl-CoA desaturase (delta-9-desaturase)
     evidenced by: QTL:31534;
   • SCMH1: Scm polycomb group protein homolog 1
     evidenced by: QTL:315103;
   • SEMA3E: Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
     evidenced by: QTL:23350;
   • SERPINA7: Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7
     evidenced by: QTL:8670; QTL:8671; QTL:8672; QTL:8673; QTL:8674;
   • SLC22A4: Solute carrier family 22 (organic cation/ergothioneine transporter), member 4
     evidenced by: QTL:23371;
   • SLC25A5: Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5
     evidenced by: QTL:1206; QTL:1212;
   • SLC26A8: Solute carrier family 26 (anion exchanger), member 8
     evidenced by: QTL:312342;
   • SLC27A6: Solute carrier family 27 member 6
     evidenced by: QTL:139261;
   • SLC39A7: Solute carrier family 39 (zinc transporter), member 7
     evidenced by: QTL:9838; QTL:9839;
   • SNRPC: Small nuclear ribonucleoprotein polypeptide C
     evidenced by: QTL:258507;
   • SOCS2: Suppressor of cytokine signaling 2
     evidenced by: QTL:9871; QTL:9872; QTL:9873; QTL:9874;
   • SOCS5: Suppressor of cytokine signaling 5
     evidenced by: QTL:259491; QTL:259492;
   • SPAG17: Sperm associated antigen 17
     evidenced by: QTL:31230;
   • SPARC: Secreted protein, acidic, cysteine-rich (osteonectin)
     evidenced by: QTL:139263;
   • STPG4: Sperm-tail PG-rich repeat containing 4
     evidenced by: QTL:259496;
   • TAS2R10: Taste 2 receptor member 10
     evidenced by: QTL:122022;
   • TAS2R16: taste 2 receptor member 16
     evidenced by: QTL:122021;
   • TAS2R38: Taste 2 receptor member 38
     evidenced by: QTL:122012; QTL:122018; QTL:122020;
   • TAS2R39: taste 2 receptor member 39
     evidenced by: QTL:122011; QTL:122013; QTL:122014; QTL:122015; QTL:122016; QTL:122017; QTL:122019;
   • TCAP: Titin-cap (telethonin)
     evidenced by: QTL:28227; QTL:28229; QTL:28230; QTL:28231; QTL:28232;
   • TECTA: Tectorin alpha
     evidenced by: QTL:31219;
   • TEF1: Transcriptional enhancer factor 1
     evidenced by: QTL:8639; QTL:8641;
   • TEX14: Testis expressed 14
     evidenced by: QTL:31229;
   • TGFBR1: Transforming growth factor, beta receptor 1
     evidenced by: QTL:31792;
   • TMEM164: Transmembrane protein 164
     evidenced by: QTL:312364; QTL:312365;
   • TMPRSS4: Transmembrane protease, serine 4
     evidenced by: QTL:31221;
   • TNC: Tenascin C
     evidenced by: QTL:17773;
   • TNF: Tumor necrosis factor
     evidenced by: QTL:126062;
   • TRIP11: Thyroid hormone receptor interactor 11
     evidenced by: QTL:259477;
   • TTC7A: Tetratricopeptide repeat domain 7A
     evidenced by: QTL:259485;
   • UCP3: Uncoupling protein 3 (mitochondrial, proton carrier)
     evidenced by: QTL:17995;
   • UHRF1BP1: UHRF1 binding protein 1
     evidenced by: QTL:258508;
   • VCAM1: Vascular cell adhesion molecule 1
     evidenced by: QTL:23177;
   • VPS13B: Vacuolar protein sorting 13 homolog B (yeast)
     evidenced by: QTL:23355;
   • VPS41: VPS41 subunit of HOPS complex
     evidenced by: QTL:216294;
   • VPS4B: Vacuolar protein sorting 4 homolog B
     evidenced by: QTL:258435; QTL:258475;
   • WNT10B: Wingless-type MMTV integration site family, member 10B
     evidenced by: QTL:15955; QTL:15956; QTL:15957; QTL:15958;
   • WNT2: Wnt family member 2
     evidenced by: QTL:126051;
   • XIRP1: Xin actin-binding repeat containing 1
     evidenced by: QTL:8647; QTL:8648; QTL:8649;
   • ZNF367: Zinc finger protein 367
     evidenced by: QTL:315105; QTL:315113;
   • ZNF391: Zinc finger protein 391
     evidenced by: QTL:259887;
   • ZNF782: Zinc finger protein 782
     evidenced by: QTL:216292;
   1265 correlations are found involving Subcutaneous fat thickness